急性心肌梗死合并心源性休克的侵入性治疗进展  

Advances in invasive treatment of acute myocardial infarction complicated by cardiogenic shock

作　　者：闫浩杰 岳帅 邵钧捷 周晶晶 张然[1] Yan Haojie;Yue Shuai;Shao Junjie;Zhou Jingjing;Zhang Ran(Department of Cardiovascular Medicine,Chinese PLA General Hospital&Chinese PLA Medical School,Beijing 100853,China)

机构地区：[1]中国人民解放军总医院心血管病医学部,北京100853

出　　处：《中国医学前沿杂志（电子版）》2023年第3期40-45,共6页Chinese Journal of the Frontiers of Medical Science(Electronic Version)

基　　金：国家重点研发计划(2021YFC2701700,2021YFC2701703)。

摘　　要：急性心肌梗死合并心源性休克(acute myocardial infarction complicated by cardiogenic shock,AMICS)严重致死致残,尽管早期心肌血运重建治疗和机械循环辅助支持显著改善AMICS预后,其死亡率仍居高不下。本文重点梳理了近年来AMICS侵入性治疗的循证医学证据和指南推荐,重点关注尽早进行心肌血运重建治疗是否获益,冠状动脉多支血管病变干预策略,以及机械循环辅助装置的选择和启动时机等。Acute myocardial infarction complicated by cardiogenic shock(AMICS)is a severely fatal and disabling condition.The mortality of AMICS remains high despite of significant improvement of prognosis by early myocardial reperfusion therapy and mechanical circulatory support.This review focuses on the evidence-based medicine and guideline recommendations for the management of AMICS in recent years,focusing on whether early myocardial reperfusion therapy is beneficial,interventional strategies of coronary multivessel lesion,and the selection and timing of mechanical circulatory assist devices.

关 键 词：急性心肌梗死 心源性休克 心肌血运重建 机械循环支持 

分 类 号：R542.22[医药卫生—心血管疾病] R541.64[医药卫生—内科学]